Overview
CYRX market data
Price History
CYRX price chart
Valuation & Profitability
- P/E (TTM)
- 9.64 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.56 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.96 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -20.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $7.61 – $16.89 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $754.7M · P/B 0.96 · P/S 4.05.
Company News
Guggenheim Maintains Buy on CryoPort, Raises Price Target to $16Benzinga · Aug 7, 2026, 4:53 PM
CryoPort shares are trading higher after the company reported better-than-expected Q2 sales results. Also, Needham maintained a Buy rating on the stock and raised its price target from $15 to $19.Benzinga · Aug 7, 2026, 12:39 PM
Needham Maintains Buy on CryoPort, Raises Price Target to $19Benzinga · Aug 7, 2026, 10:04 AM
Conference Call: CryoPort Affirms FY2026 Sales Guidance of $192.000M-$196.000M vs $194.390M EstBenzinga · Aug 6, 2026, 10:21 PM
CryoPort Q2 Adj. EPS $(0.20) Misses $(0.19) Estimate, Sales $48.971M Beat $48.207M EstimateBenzinga · Aug 6, 2026, 8:08 PM
BTIG Maintains Buy on CryoPort, Raises Price Target to $25Benzinga · Jul 24, 2026, 10:27 AM
Cryoport’s IntegriCell Cryopreservation Services Selected By Verismo Therapeutics To Support SynKIR-110 And SynKIR-310 Multi-Chain KIR-CAR ProgramsBenzinga · Jun 25, 2026, 12:15 PM
Craig-Hallum Maintains Buy on CryoPort, Raises Price Target to $20Benzinga · Jun 3, 2026, 5:40 PM
Keybanc Maintains Overweight on CryoPort, Raises Price Target to $17Benzinga · May 20, 2026, 2:50 PM